Marc Beer is a B.S degree holder and also serves as a member of the Business Advisory Council at Miami University. He also is a former member of Notre Dame Graduate Studies Research advisory council and its Commercialization Advisory Committee Marc Beer is a prominent personality with his success as a medical practitioner having played a major role towards the increasing growth in matters pertaining inventions of biotechnology and pharmaceutical products with some of his establishments include serving as a Vice President of Global marketing for Genzyme, founding chief executive officer for Good Start Genetics’ compensation committee and ViaCell biotech company which was dedicated to the collection, preservation and development of blood stem cells and umbilical cord which under his leadership expanded into a big commercial organization before its acquisition by PerkinElmer.
Prior to joining Genzyme, he has worked for Abbott Laboratories in different capacities in the sales and marketing docket along other involvements in Biotechnology Industry Organization (BIO) and the Mass Life Board Science. Mr. Marc Beer has also served as a founding chairman of Minerva Neuroscience Inc. the company is known to develop and produce products aimed at treating diseases related to the Central Nervous System, and remedies to treat depression disorders, Parkinson’s disease, insomnia among other disorders. Among his recent establishment is founding Renovia Inc. in 2016 which is dedicated to research and treatment of women with pelvic floor disorders.
Recently, Marc Beer was appointed the chairman of the Board of LumeNXT Inc. where he is expected to employ his over 25 years’ experience in diagnostics, pharmaceutical devices and biotechnology to his new position. Marc Beer responded on having the privilege of working with experts in surgical illumination technology towards safety delivery of surgical processes. This technology is currently gaining fame due to its flexibility over the traditional techniques as patients will not experience deep invasive incision approaches.
LumeNXT is a private-based company with focus on the utilization of the Light Emitting Diodes (LED) illumination comprising of surgeons and engineers with skills in surgical illumination technology who specialize in developing surgical illumination products to enhance precision and visualization to safe surgical processes. According the LumeNXT co-founder Mr. Paul Rhyne, he is opportunistic of Marc Beer’s experience and his capability in propelling healthcare base industries to profit margins.
Marc Beer is excited by the changing trends in technology especially in the field of healthcare with multiple innovations towards digitizing health matters. He is also passionate of championing for women Health through Renovia. This is evident with his exemplary act towards women health by his contribution of $42M kitty for funding women health startup through development of diagnostic and therapeutic treatment devices to be used for treatment of pelvic floor disorders. Learn more: https://www.businesswire.com/news/home/20180821005199/en/Renovia-Completes-42.3-Million-Series-Financing